Ethics In Spotlight As Scientists Jumpstart Precision Medicine In China
This article was originally published in PharmAsia News
Executive Summary
Researchers like Harvard professor Sunny Xiaoliang Xie, who is spearheading the development of China’s first domestic genome sequencer, are carefully navigating tricky terrain while leading the charge to reduce the country’s huge birth deficiency burden and tackle next-generation cancer therapies.